Literature DB >> 8359002

Identification of clinical isolates of nondiphtherial Corynebacterium species and their antibiotic susceptibility patterns.

D Y Williams1, S T Selepak, V J Gill.   

Abstract

Starting in 1982, our laboratory has performed species identification of coryneform bacteria isolated from blood cultures, intravenous (i.v.) catheter tips and sites, urines with high colony counts, and other potentially significant cultures, using predefined criteria. Of 283 isolates identified, Corynebacterium jeikeium was the most common (47%), followed by CDC group G2 (12%) and C. minutissimum (8%). Blood cultures and i.v. catheter-related sources were the most frequent sources (58% of total). Certain species or groups, like CDC group G2, were most frequently isolated from blood or i.v. catheter sites. CDC group G2 showed a progression to greater multiple antibiotic resistance during this 9-year period. Occasional multiresistant strains of other species were also encountered. By in vitro testing, we note vancomycin remains the most active agent against corynebacterialike organisms, and is the most reliable antibiotic to use while awaiting susceptibility testing results.

Entities:  

Mesh:

Year:  1993        PMID: 8359002     DOI: 10.1016/0732-8893(93)90065-f

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  13 in total

1.  Identification of non-diphtheriae corynebacterium by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry.

Authors:  Adnan A Alatoom; Charles J Cazanave; Scott A Cunningham; Sherry M Ihde; Robin Patel
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

2.  Corynebacterium tuberculostearicum: a potentially misidentified and multiresistant Corynebacterium species isolated from clinical specimens.

Authors:  V Hinic; C Lang; M Weisser; C Straub; R Frei; D Goldenberger
Journal:  J Clin Microbiol       Date:  2012-05-16       Impact factor: 5.948

3.  Species identities and antimicrobial susceptibilities of corynebacteria isolated from various clinical sources.

Authors:  P Riegel; R Ruimy; R Christen; H Monteil
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-08       Impact factor: 3.267

4.  In vitro susceptibilities of aerobic and facultative non-spore-forming gram-positive bacilli to HMR 3647 (RU 66647) and 14 other antimicrobials.

Authors:  F Soriano; R Fernández-Roblas; R Calvo; G García-Calvo
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

5.  Corynebacterium falsenii bacteremia occurring in an infant on vancomycin therapy.

Authors:  Pui-Ying Iroh Tam; Mark A Fisher; Nancy S Miller
Journal:  J Clin Microbiol       Date:  2010-07-07       Impact factor: 5.948

Review 6.  Clinical microbiology of coryneform bacteria.

Authors:  G Funke; A von Graevenitz; J E Clarridge; K A Bernard
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

7.  Catheter-related Corynebacterium bacteremia: should the catheter be removed and vancomycin administered?

Authors:  S Ghide; Y Jiang; R Hachem; A-M Chaftari; I Raad
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-12-17       Impact factor: 3.267

8.  Comparison of antimicrobial susceptibilities of Corynebacterium species by broth microdilution and disk diffusion methods.

Authors:  K Weiss; M Laverdière; R Rivest
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

9.  Antimicrobial susceptibilities of Corynebacterium species and other non-spore-forming gram-positive bacilli to 18 antimicrobial agents.

Authors:  F Soriano; J Zapardiel; E Nieto
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

10.  Genomic diversity among Corynebacterium jeikeium strains and comparison with biochemical characteristics and antimicrobial susceptibilities.

Authors:  P Riegel; D de Briel; G Prévost; F Jehl; H Monteil
Journal:  J Clin Microbiol       Date:  1994-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.